Software Validation Study-Cognitive Status Indicator

Up to 600 subjects (and informants) may be enrolled and have a brain scan, cognitive, and blood assessments collected:

Visit 1-Screening:

-Salzburg (SDTP)- remote via telephone or video visit

Visit 2/3-Evaluations:

• EEG Scan (brain scan)
• Mini-Mental State Exam (MMSE)-at home visit
• Functional Assessment Staging Tool (FAST)- at home via video visit
• blood- Amyloid Beta 42/40 ratio, p tau- at laboratory or home visit There are three instances of subject engagement with the study team after informed consent. One, during screening which may be a remote visit and and two different home or remote visits (or laboratory visit). The study participation ends when all of the assessments have been collected. The total duration of subject participation should be no more than 2-3 days within a 90 day period.

The output of the investigational software used in the analysis to determine a identification of cognitive and Alzheimer's status based the data from the EEG scan shall be compared to the identification of cognitive and Alzheimer's status from a group of dementia specialists forming an Adjudication Committee which shall review all data (except for investigational device output).

Inclusion criteria

Unimpaired subjects:

To be eligible to participate in this study, an individual must meet all of the following criteria:

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 65 to 90 at the time of consent
• Have a Salzburg Dementia Test Prediction (SDTP) score >= 24.
• Informant, available and willing (remotely or in-person) to provide information about subject cognitive functioning
• No Medical History of cognitive impairment

Mild Cognitive Impairment subjects:

To be eligible to participate in this study, an individual must meet all of the following criteria:

• 1. Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 65 to 90 at the time of consent
• Have a Salzburg Dementia Test Prediction (SDTP) score < 24.
• Informant, available and willing (remotely or in-person) to provide information about subject cognitive functioning
• Suspected or diagnosed with a mild cognitive issue

Dementia subjects:

To be eligible to participate in this study, an individual must meet all of the following criteria:

• Provision of signed and dated informed consent form-legally authorized representative or individual
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 65 to 90 at the time of consent
• Have a Salzburg Dementia Test Prediction (SDTP) score < 24.
• Informant, available and willing (remotely or in-person) to provide information about subject cognitive functioning
• Exhibiting and diagnosed with moderate or severe cognitive issue

Informants:

To be eligible to participate as an informant in this study, an individual must meet all of the following criteria:

• Provision of signed and dated informed consent form 2. Typically spends 2 or more hours per month with subject. 3. Available and willing (remotely or in-person) to provide information about subject cognitive functioning

-

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

• Currently experiencing a skin disease on scalp that would affect electrode contacts in the opinion of the user

-